Registered entities
Locus Pharmaceuticals, Inc.
Reg. No. 22-3672904United States
Investor mix
8 investors on record; lead investors include HBM Healthcare Investments, Prism Venture Partners, Novartis Venture Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 75% |
| Angel & family office | 1 | 13% |
| Other / undisclosed | 1 | 13% |